China (Mainland)
Imatinib Mesylate CAS NO.220127-57-1
- Min.Order: 0 Metric Ton
- Payment Terms:
- Product Details
Keywords
- Imatinib Mesylate
- IHS
- competitive price
Quick Details
- ProName: Imatinib Mesylate
- CasNo: 220127-57-1
- Molecular Formula: C30H35N7O4S
- Appearance: Off-White Solid
- Application: Antineoplastic
- DeliveryTime: 15 days after order confirmed
- PackAge: 25kg/drum
- Port: shanghai or hangzhou
- ProductionCapacity: Metric Ton/Day
- Purity: 98%
- LimitNum: 0 Metric Ton
Superiority
1.Quality gurantee
2.Safe & Fast shipping since we have long reliable co-operated shiping companies
3.Prompty
4.Exfactory price, very competitive.
5.Provide great service
Details
| Imatinib mesylate Usage And Synthesis |
| a small-molecule inhibitor |
Imatinib mesylate (also called Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia. As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of dermatological diseases. Imatinib has been reported to be an effective treatment for FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans. |
| Chemical Properties | Off-White Solid |
| Usage | A tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL) |
| Usage | Imatinib Mesylate is orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM, respectively. Imatinib also known as Gleevec, Glivec, CGP-57148B, STI-571 & Imatinib |
| Usage | Imatinib Mesylate (STI571) is an orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM, respectively. |
| Usage | echinocandin antifungal, active against infections with Aspergillus and Candida, inhibits cell wall synthesis |